Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Ethical decision-making in bioscience firms

Nature Biotechnology volume 24, pages 285–290 (2006)Cite this article

A survey of the ethical practices of bioscience companies suggests that although most firms feature ethics in their mission statement or code of conduct, fewer than half of the companies surveyed have made any formal efforts to assess how well these approaches are working.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: What do you consider the most important reasons for your organization to focus on ethical issues?
Figure 2
Figure 3
Figure 4

References

  1. Harris, G. As doctor writes prescription, drug company writes a check. The New York Times, June 27 (2004), p.1.

    Google Scholar 

  2. Harris, G. Guilty plea seen for drug maker. The New York Times, July 16 (2004), p. 1.

    Google Scholar 

  3. Lenzer, J. Scandals have eroded US public's confidence in drug industry. Br. Med. J. 329, 247 (2004).

    Google Scholar 

  4. Kaufman, M. Drugs get good ratings, but drug-makers less so. Washington Post, February 26, (2005), p. A3.

    Google Scholar 

  5. Eaton, M.L. Ethics and the Business of Bioscience (Stanford University Press, Stanford, 2004).

    Google Scholar 

  6. Finegold, D. et al. BioIndustry Ethics (Academic Press, New York, 2005).

    Google Scholar 

Download references

Acknowledgements

The authors thank Deborah Flynn for help with the survey instrument and excellent administrative support, Steve Casper for his helpful suggestions and Tiffany Sun for advice and editing. Funding for this research was provided by the Seaver Institute, a Los Angeles-based foundation.

Author information

Authors and Affiliations

  1. Keck Graduate Institute of Applied Life Sciences, 535 Watson Drive, Claremont, 91711, California, USA

    David Finegold & Allison Moser

  2. Pomona College, Claremont, 91711, California, USA

    David Finegold & Allison Moser

Authors
  1. David Finegold
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allison Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finegold, D., Moser, A. Ethical decision-making in bioscience firms. Nat Biotechnol 24, 285–290 (2006). https://doi.org/10.1038/nbt0306-285

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0306-285

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing